CENTER ID: | NafoA.00379.a |
ORGANISM: | Naegleria fowleri ATCC 30863 |
ASSOCIATED DISEASE: | |
CURRENT STATUS: | in PDB |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
IIB |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
NafoA.00379.a.B4.GE44253 | ENO2 truncation 2 | 62 | 512 | ||
NafoA.00379.a.B5.GE44254 | ENO2 truncation 3 | 44 | 512 |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
NafoA.00379.a.B4.PW38978 | ENO2 truncation 2 | 62 | 512 | ||
NafoA.00379.a.B5.PW38980 | ENO2 truncation 3 | 44 | 512 | ||
NafoA.00379.a.B5.PW39044 | ENO2 truncation 3 | 44 | 512 | ||
NafoA.00379.a.B5.PW39046 | ENO2 truncation 3 | 44 | 512 | ||
NafoA.00379.a.B4.PW39047 | ENO2 truncation 2 | 62 | 512 |
RESOURCE | REFERENCE ID |
---|---|
EuPathDB: | AmoebaDB:NF0118810 |
HARVESTED ON: | 4/1/2021 |
SEQUENCED ON: | 4/13/2021 |
EXPECTED MW: | 50kDa |
OBSERVED MW: | 50kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | High Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | data unavailable |
PERCENT COVERAGE: | data unavailable |
HARVESTED ON: | 4/1/2021 |
SEQUENCED ON: | 4/13/2021 |
EXPECTED MW: | 52kDa |
OBSERVED MW: | 52kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | High Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 95 |
PERCENT COVERAGE: | 63 |
PURIFICATION DATe: | 4/19/2021 |
CONCENTRATION: | 26mg/ml |
OBSERVED MW: | 50kDa |
EXPRESSION LEVEL: | Moderate Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 8 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | data unavailable |
PERCENT COVERAGE: | data unavailable |
PURIFICATION DATe: | 4/21/2021 |
CONCENTRATION: | 36mg/ml |
OBSERVED MW: | 52kDa |
EXPRESSION LEVEL: | Moderate Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 6 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | 95 |
PERCENT COVERAGE: | 63 |
PURIFICATION DATe: | 6/11/2021 |
CONCENTRATION: | 54mg/ml |
OBSERVED MW: | 52kDa |
EXPRESSION LEVEL: | Low Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 4 |
VIAL VOLUME: | 50µl |
PERCENT IDENTITY: | 95 |
PERCENT COVERAGE: | 63 |
PURIFICATION DATe: | 6/25/2021 |
CONCENTRATION: | 73mg/ml |
OBSERVED MW: | 52kDa |
EXPRESSION LEVEL: | Moderate Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 4 |
VIAL VOLUME: | 52µl |
PERCENT IDENTITY: | 95 |
PERCENT COVERAGE: | 63 |
PURIFICATION DATe: | 7/22/2021 |
CONCENTRATION: | 45mg/ml |
OBSERVED MW: | 50kDa |
EXPRESSION LEVEL: | High Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 6 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | data unavailable |
PERCENT COVERAGE: | data unavailable |